Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026)
Bausch & Lomb (BLCO) reported Income from Non-Controlling Interests of $1.0 million for Q1 2026, little changed on a YoY basis from $1.0 million in Q1 2025, and down 66.67% quarter-over-quarter from $3.0 million in Q3 2025.
Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Income from Non-Controlling Interests for 6 years, with the latest figure at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests changed 0.0% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (down 11.11% YoY), and the FY2025 full-year result was $8.0 million, down 33.33% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $1.0 million, down from $3.0 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $4.0 million in Q3 2023, with the low at $1.0 million in Q4 2022.
- Historically, Income from Non-Controlling Interests has averaged $2.6 million across 5 years, with a median of $3.0 million in 2022.
- Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests surged 200.0% — and 2025, when it sank 75.0%.
- Bausch & Lomb's Income from Non-Controlling Interests stood at $1.0 million in 2022, then surged by 200.0% to $3.0 million in 2023, then slumped by 66.67% to $1.0 million in 2024, then surged by 200.0% to $3.0 million in 2025, then slumped by 66.67% to $1.0 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $1.0 million (Q1 2026), $3.0 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Mar 31, 2021 | 3.00 Mn |